Airain Ltd’s Ionis Pharmaceuticals IONS Stock Holding History

Airain Ltd’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-37,354	Closed	-$2.15M	–	956
2015 Q2	$2.15M	Buy	+37,354	New	+$2.38M	0.12%	201
2014 Q1	–	Sell	-35,928	Closed	-$1.43M	–	775
2013 Q4	$1.43M	Buy	+35,928	New	+$1.28M	0.19%	142

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Airain Ltd's IONS Position: Q3 2015 in Review

Airain Ltd sold out of Ionis Pharmaceuticals (IONS) in Q3 2015, closing a stake of 37,354 shares — an estimated $2.15M sold.

Airain Ltd first reported a position in IONS in Q4 2013 and held it in 2 quarters. The position peaked at $2.15M in Q2 2015. 314 funds tracked by Wall St. Rank hold IONS as of Q3 2015.

Airain Ltd reported no remaining Ionis Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
Airain Ltd sold 37,354 Ionis Pharmaceuticals shares in Q3 2015, an estimated $2.15M.
Airain Ltd first reported a position in Ionis Pharmaceuticals in Q4 2013 and held it in 2 quarters.
Airain Ltd's Ionis Pharmaceuticals position peaked at $2.15M in Q2 2015.
314 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2015.

Based on Airain Ltd's 13F filing for Q3 2015, filed 9 Nov 2015.